CompletedNot Applicable

The Visceral Adiposity Measurement and Observation Study

United States196 participantsStarted 2022-04-18

Plain-language summary

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Detectable HIV plasma viremia 12 months prior enrollment, defined by ≥1 measurement of HIV-1 ribonucleic acid (RNA) \> 1000/mL
✕. Unable or unwilling to undergo any study procedures
✕. Known hepatic cirrhosis
✕. Active hepatitis C within past 12 months, defined by detectable hepatitis C RNA
✕. Hepatitis B positive
✕. Current pregnancy or breastfeeding
✕. History of liver transplant
✕. Self-reported weekly alcohol consumption meets National Institute on Alcohol Abuse and Alcoholism (NIAAA) criteria for problematic drinking (binge or chronic daily intake)

Umbilical waist circumference measurement (in cm).

Timeframe: Baseline

Iliac waist circumference measurement (in cm).

Timeframe: Baseline

Visceral Adiposity Measurement by CT surface area (cm2).

Timeframe: Baseline

NCT IDNCT05383456

SponsorTheratechnologies

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-10-30